PPFIA2
Basic information
Region (hg38): 12:81257975-81759553
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPFIA2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 43 | 45 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 43 | 4 | 2 |
Variants in PPFIA2
This is a list of pathogenic ClinVar variants found in the PPFIA2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-81263269-G-T | not specified | Uncertain significance (Aug 17, 2022) | ||
12-81263380-T-C | not specified | Uncertain significance (Sep 16, 2021) | ||
12-81266993-T-C | not specified | Uncertain significance (Nov 10, 2022) | ||
12-81267926-T-C | not specified | Uncertain significance (Sep 14, 2023) | ||
12-81268043-C-T | Benign (Jun 27, 2018) | |||
12-81277345-T-G | not specified | Uncertain significance (Dec 13, 2021) | ||
12-81294958-T-G | not specified | Uncertain significance (Jun 03, 2024) | ||
12-81295039-TTAGA-T | Benign (Jun 05, 2018) | |||
12-81325815-G-A | Likely benign (Aug 01, 2022) | |||
12-81325819-T-C | not specified | Uncertain significance (Jan 09, 2024) | ||
12-81325856-T-C | not specified | Uncertain significance (May 05, 2023) | ||
12-81339194-C-T | not specified | Uncertain significance (Aug 15, 2023) | ||
12-81339294-C-G | not specified | Uncertain significance (Jul 09, 2021) | ||
12-81341090-T-C | not specified | Uncertain significance (Feb 07, 2023) | ||
12-81341204-G-T | not specified | Uncertain significance (Apr 26, 2023) | ||
12-81347548-C-T | not specified | Uncertain significance (Jan 10, 2023) | ||
12-81347553-G-A | not specified | Uncertain significance (Dec 18, 2023) | ||
12-81347600-T-C | not specified | Uncertain significance (Mar 08, 2024) | ||
12-81347609-G-A | not specified | Uncertain significance (Mar 04, 2024) | ||
12-81347622-T-C | not specified | Uncertain significance (Mar 19, 2024) | ||
12-81347630-G-A | not specified | Uncertain significance (Apr 29, 2024) | ||
12-81347683-A-G | Benign (Dec 31, 2019) | |||
12-81353170-G-A | not specified | Uncertain significance (Nov 09, 2023) | ||
12-81353186-G-A | not specified | Uncertain significance (Mar 18, 2024) | ||
12-81353224-G-A | not specified | Uncertain significance (Dec 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PPFIA2 | protein_coding | protein_coding | ENST00000549396 | 30 | 501288 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 3.85e-9 | 124187 | 0 | 359 | 124546 | 0.00144 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.26 | 406 | 638 | 0.637 | 0.0000334 | 8109 |
Missense in Polyphen | 91 | 234.33 | 0.38834 | 2948 | ||
Synonymous | -0.505 | 230 | 220 | 1.04 | 0.0000112 | 2350 |
Loss of Function | 7.51 | 5 | 75.4 | 0.0663 | 0.00000435 | 916 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00129 | 0.00124 |
Ashkenazi Jewish | 0.000202 | 0.000199 |
East Asian | 0.000352 | 0.000334 |
Finnish | 0.00920 | 0.00900 |
European (Non-Finnish) | 0.00119 | 0.00114 |
Middle Eastern | 0.000352 | 0.000334 |
South Asian | 0.00 | 0.00 |
Other | 0.000682 | 0.000661 |
dbNSFP
Source:
- Function
- FUNCTION: Alters PTPRF cellular localization and induces PTPRF clustering. May regulate the disassembly of focal adhesions. May localize receptor-like tyrosine phosphatases type 2A at specific sites on the plasma membrane, possibly regulating their interaction with the extracellular environment and their association with substrates. {ECO:0000269|PubMed:9624153}.;
- Pathway
- Neuronal System;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Acetylcholine Neurotransmitter Release Cycle;Neurotransmitter release cycle;Receptor-type tyrosine-protein phosphatases;Transmission across Chemical Synapses;Protein-protein interactions at synapses;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle
(Consensus)
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- loftool
- 0.158
- rvis_EVS
- -1.04
- rvis_percentile_EVS
- 7.77
Haploinsufficiency Scores
- pHI
- 0.377
- hipred
- Y
- hipred_score
- 0.750
- ghis
- 0.605
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.586
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ppfia2
- Phenotype
- vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- cell-matrix adhesion;presynapse organization;regulation of synaptic vesicle exocytosis
- Cellular component
- cytoplasm;cytosol;cell surface;presynaptic active zone;extracellular exosome;glutamatergic synapse
- Molecular function
- protein binding;structural constituent of presynapse